Application of quality control circle in increasing the number of follow-up patients in the chronic kidney disease management_West China Medical Journal

Authors：

LONG Yanqiong , DUAN Difei , YAN Yu , LIU Min , LI Xingcheng ,  MA Dengyan

Department of Nephrology, West China Hospital, Sichuan University / West China School of Nursing, Sichuan University, Chengdu, Sichuan 610041, P. R. China;

Corresponding?author：

MA Dengyan, Email: mdy5104@163.com

Keywords：

Quality control circle; follow up; chronic disease management; chronic kidney disease

DOI：

10.7507/1002-0179.202106021

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To evaluate the application effect of quality control circle (QCC) in improving the number of cases received in the follow-up management of chronic kidney disease (CKD). Methods The outpatient and inpatient CKD patients who were filed in the CKD follow-up management center of West China Hospital of Sichuan University from March 10 to October 10, 2020 were selected. We analyzed the reasons that affected CKD patients’ willingness to file by carrying out QCC, improved the case collection by establishing standardized processes, broadened the collection channels, established a collective team, strengthened training management and education of CKD patients and their families, so as to increase the number of cases received in CKD follow-up management. Then, we observed the score of active ability of QCC members before and after this activity. Results After the implementation of QCC activities, the number of follow-up cases increased from 8 per month to 15 per month. The target achievement rate was 140%, and the progress rate was 87.5%. The ability of all circle members in the evaluation indicators of team training has been improved. Conclusions QCC activity can effectively improve the number of cases received in CKD follow-up management. It is helpful for the medical staff to provide better disease management for CKD patients.

Citation： LONG Yanqiong, DUAN Difei, YAN Yu, LIU Min, LI Xingcheng, MA Dengyan. Application of quality control circle in increasing the number of follow-up patients in the chronic kidney disease management. West China Medical Journal, 2022, 37(1): 74-79. doi: 10.7507/1002-0179.202106021 Copy

1.	Yang C, Wang H, Zhao X, et al. CKD in China: evolving spectrum and public health implications. Am J Kidney Dis, 2020, 76(2): 258-264.
2.	GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet, 2020, 395(10225): 709-733.
3.	康陽陽, 劉章鎖, 劉東偉. 中國成人慢性腎臟病患病率薈萃分析. 中國實用內科雜志, 2016, 36(9): 785-789.
4.	Ortiz A, Covic A, Fliser D, et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet, 2014, 383(9931): 1831-1843.
5.	Zhang L, Zhao MH, Zuo L, et al. China kidney disease network (CK-NET) 2015 annual data report. Kidney Int Suppl(2011), 2019, 9(1): e1-e81.
6.	Wang SM, Hsiao LC, Ting IW, et al. Multidisciplinary care in patients with chronic kidney disease: a systematic review and meta-analysis. Eur J Intern Med, 2015, 26(8): 640-645.
7.	Hsu HT, Chiang YC, Lai YH, et al. Effectiveness of multidisciplinary care for chronic kidney disease: a systematic review. Worldviews Evid Based Nurs, 2021, 18(1): 33-41.
8.	馬登艷, 張穎君, 陳懿, 等. 多學科整合模式在慢性腎臟病病人門診隨訪管理中的應用. 護理研究, 2016, 30(24): 3017-3020.
9.	National Kidney Foundation. Kidney disease outcomes quality initiative clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis, 2000, 35 (6 Suppl 2): S1-S140.
10.	劉庭芳, 劉勇. 中國醫院品管圈操作手冊. 北京: 人民衛生出版社, 2012: 270-284.
11.	Feng H, Li G, Xu C, et al. A quality control circle process to improve implementation effect of prevention measures for high‐risk patients. Int Wound J, 2017, 14(6): 1094-1099.
12.	Anand Jayakumar A, Krishnaraj C. Quality circle-formation and implementation. Int J Emerg Technol Eng Res, 2015, 2(2): 122-124.
13.	杜曄, 孟群. 我國慢性腎臟病防治政策及策略研究—基于衛生經濟學視角. 中國衛生政策研究, 2018, 11(7): 78-83.
14.	Xu H, Mou L, Cai Z. A nurse-coordinated model of care versus usual care for chronic kidney disease:meta-analysis. J Clin Nurs, 2017, 26(11/12): 1639-1649.
15.	Andrassy KM. Comments on ‘KDIGO 2012 cinical practice guideline for the evaluation and management of chronic kidney disease’. Kidney Int, 2013, 84(3): 622-623.
16.	Hirano K, Kobayashi D, Kohtani N, et al. Optimal follow-up intervals for different stages of chronic kidney disease: a prospective observational study. Clin Expe Nephrol, 2019, 23(5): 613-620.
17.	Iseki K, Miyasato F, Uehara H, et al. Outcome study of renal biopsy patients in Okinawa, Japan. Kidney Int, 2004, 66(3): 914-919.
18.	潘永毅, 謝文鴻, 李梅, 等. 門診慢性腎臟病病人積極度現狀及其影響因素. 護理研究, 2019, 33(22): 3935-3939.
19.	陳艷, 石鈺, 于智凱, 等. 不同隨訪頻率對慢性腎臟病患者隨訪管理效果的影響. 檢驗醫學與臨床, 2020, 17(1): 13-16.
20.	Chen P, Yuan T, Sun QF, et al. Role of quality control circle in sustained improvement of hand hygiene compliance: an observational study in a stomatology hospital in Shandong, China . Antimicrob Resist Infect Control, 2016, 5: 54.
21.	Zhu LL, Li W, Song P, et al. Injection device-related risk management toward safe administration of medications: experience in a university teaching hospital in the People’s Republic of China. Ther Clin Risk Manag, 2014, 10: 165-172.

1. Yang C, Wang H, Zhao X, et al. CKD in China: evolving spectrum and public health implications. Am J Kidney Dis, 2020, 76(2): 258-264.
2. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the global burden of disease study 2017. Lancet, 2020, 395(10225): 709-733.
3. 康陽陽, 劉章鎖, 劉東偉. 中國成人慢性腎臟病患病率薈萃分析. 中國實用內科雜志, 2016, 36(9): 785-789.
4. Ortiz A, Covic A, Fliser D, et al. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure. Lancet, 2014, 383(9931): 1831-1843.
5. Zhang L, Zhao MH, Zuo L, et al. China kidney disease network (CK-NET) 2015 annual data report. Kidney Int Suppl(2011), 2019, 9(1): e1-e81.
6. Wang SM, Hsiao LC, Ting IW, et al. Multidisciplinary care in patients with chronic kidney disease: a systematic review and meta-analysis. Eur J Intern Med, 2015, 26(8): 640-645.
7. Hsu HT, Chiang YC, Lai YH, et al. Effectiveness of multidisciplinary care for chronic kidney disease: a systematic review. Worldviews Evid Based Nurs, 2021, 18(1): 33-41.
8. 馬登艷, 張穎君, 陳懿, 等. 多學科整合模式在慢性腎臟病病人門診隨訪管理中的應用. 護理研究, 2016, 30(24): 3017-3020.
9. National Kidney Foundation. Kidney disease outcomes quality initiative clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis, 2000, 35 (6 Suppl 2): S1-S140.
10. 劉庭芳, 劉勇. 中國醫院品管圈操作手冊. 北京: 人民衛生出版社, 2012: 270-284.
11. Feng H, Li G, Xu C, et al. A quality control circle process to improve implementation effect of prevention measures for high‐risk patients. Int Wound J, 2017, 14(6): 1094-1099.
12. Anand Jayakumar A, Krishnaraj C. Quality circle-formation and implementation. Int J Emerg Technol Eng Res, 2015, 2(2): 122-124.
13. 杜曄, 孟群. 我國慢性腎臟病防治政策及策略研究—基于衛生經濟學視角. 中國衛生政策研究, 2018, 11(7): 78-83.
14. Xu H, Mou L, Cai Z. A nurse-coordinated model of care versus usual care for chronic kidney disease:meta-analysis. J Clin Nurs, 2017, 26(11/12): 1639-1649.
15. Andrassy KM. Comments on ‘KDIGO 2012 cinical practice guideline for the evaluation and management of chronic kidney disease’. Kidney Int, 2013, 84(3): 622-623.
16. Hirano K, Kobayashi D, Kohtani N, et al. Optimal follow-up intervals for different stages of chronic kidney disease: a prospective observational study. Clin Expe Nephrol, 2019, 23(5): 613-620.
17. Iseki K, Miyasato F, Uehara H, et al. Outcome study of renal biopsy patients in Okinawa, Japan. Kidney Int, 2004, 66(3): 914-919.
18. 潘永毅, 謝文鴻, 李梅, 等. 門診慢性腎臟病病人積極度現狀及其影響因素. 護理研究, 2019, 33(22): 3935-3939.
19. 陳艷, 石鈺, 于智凱, 等. 不同隨訪頻率對慢性腎臟病患者隨訪管理效果的影響. 檢驗醫學與臨床, 2020, 17(1): 13-16.
20. Chen P, Yuan T, Sun QF, et al. Role of quality control circle in sustained improvement of hand hygiene compliance: an observational study in a stomatology hospital in Shandong, China . Antimicrob Resist Infect Control, 2016, 5: 54.
21. Zhu LL, Li W, Song P, et al. Injection device-related risk management toward safe administration of medications: experience in a university teaching hospital in the People’s Republic of China. Ther Clin Risk Manag, 2014, 10: 165-172.

Previous Article
Influence of resistance training intensity on glycosylated hemoglobin in elderly patients with type 2 diabetes: a meta-analysis
Next Article
Lung repair and remodeling after injury

West China Medical Journal

Application of quality control circle in increasing the number of follow-up patients in the chronic kidney disease management

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content